Short answer
Ispire Technology Inc. (ISPR) filed its Q1 2026 10-Q quarterly report on May 7, 2026 for the quarter ended Mar 31, 2026. Quarterly revenue was $19M (down 28.7% year over year) with net income of −$10M.
Q1 2026 key financials · XBRL
- Revenue
- $19M
- −28.7% YoY · −7.9% QoQ
- Net income
- −$10M
- +12.3% YoY · −44.2% QoQ
- Operating margin
- -50.8%
- Gross margin
- 10.7%
- EPS (diluted)
- −$0.17
- +10.5% YoY · −54.5% QoQ
Source: XBRL data from the Ispire Technology Inc. (ISPR) Q1 2026 10-Q on SEC EDGAR. USD.
Ispire Technology Inc. Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Quarterly revenue, YoY change, and profitability percentages not provided in supplied MD&A
- Malaysia nicotine manufacturing license secured March 17, 2026
- Malaysia nicotine production expected to commence end of June 2026
- Operating cash flow improvement expected during 2026
- Positive cash flow targeted in first half of fiscal 2027, subject to execution and market conditions
Risk Factors
- Negative cash flows remain material, with positive cash flow targeted for the first half of fiscal 2027
- China nicotine-vapor policies, global trade policy, and Malaysian supply-chain partnerships could delay cash-flow improvement
- IKE’s FDA component PMTA, submitted April 2025 after a November 13, 2024 FDA meeting, may fail
- Joint-venture financing could dilute Ispire’s 40% IKE and 49% Jin Wu ownership interests
- Ispire had $8,839,130 invested in and advanced to IKE as of March 31, 2026
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Ispire Technology Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.